Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

METHYLPHENIDATE

METHYLPHENIDATE

Standard Dose
8.6MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview METHYLPHENIDATE is listed in Drugs@FDA under application 210924 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient METHYLPHENIDATE Form and strength TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - 8.6MG Sponsor ACTAVIS ELIZABETH Submission history Latest submission status date: 2020-06-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview METHYLPHENIDATE is listed in Drugs@FDA under application 210924 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient METHYLPHENIDATE Form and strength TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - 8.6MG Sponsor ACTAVIS ELIZABETH Submission history Latest submission status date: 2020-06-19 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.